Скачать или смотреть Basophil Activation Test for assessing IgE-mediated responses in drug hypersensitivity

Reference: https://app.jove.com/t/3263/basophil-...
The Basophil Activation Test (BAT) serves as a crucial diagnostic tool for exploring IgE-mediated mechanisms involved in drug hypersensitivity reactions. This test is particularly valuable in identifying specific allergens that trigger adverse responses in sensitized individuals. By analyzing the activation of basophils, which are a type of white blood cell involved in allergic reactions, clinicians can gain insights into the underlying immunological processes. The BAT measures the expression of activation markers on basophils upon exposure to suspected drugs, providing a direct assessment of the immune response associated with IgE antibodies.

In the context of drug hypersensitivity, the BAT offers several advantages over traditional methods, such as skin prick tests or drug provocation tests, which may carry higher risks for patients. The test is performed using a small blood sample, making it a safer alternative for individuals with a history of severe allergic reactions. Furthermore, the BAT can detect sensitization to multiple drugs simultaneously, allowing for a comprehensive evaluation of a patient's hypersensitivity profile. This capability is particularly beneficial in cases where patients are on multiple medications, as it helps to pinpoint specific culprits responsible for adverse reactions.

The interpretation of BAT results requires careful consideration of various factors, including the patient's clinical history and the specific drugs involved. A positive result indicates that the basophils have been activated in response to the drug, suggesting an IgE-mediated hypersensitivity. However, it is essential to correlate these findings with clinical symptoms and other diagnostic tests to establish a definitive diagnosis. As research continues to advance in this field, the BAT is expected to play an increasingly significant role in the personalized management of drug allergies, ultimately improving patient safety and treatment outcomes.